Eric Guirguis, DDS
Oral and Maxillofacial Surgery · Westlake, OHNPI 1831234533
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $3,000 of the $3,730 with a category attached, or 80.4%. Dentsply IH Inc. accounts for 80.4% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $3,082 and has fallen 99.5% since, to $15 in 2024.
Across 30 payments — averaging $124.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dentsply IH Inc.$3K
- Straumann USA LLC$385
- Biohorizons Implant Systems Inc.$211
- Geistlich Pharma, North America, Inc.$82
- Purelife, LLC$20
- Nobel Biocare USA$17
- plus $15 from 1 others
What the payments were for
- Speaking & faculty fees$3,00080%
- Food & beverage$61016%
- Education$1003%
- Gifts$201%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dentsply IH Inc. | 1 | $3,000 |
| Straumann USA LLC | 13 | $385 |
| Biohorizons Implant Systems Inc. | 12 | $211 |
| Geistlich Pharma, North America, Inc. | 1 | $82 |
| Purelife, LLC | 1 | $20 |
| Nobel Biocare USA | 1 | $17 |
| Patterson Companies, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Implant Dentistry$3,000
How this compares
$3,730 in reported general payments places this provider in the 85th percentile of 220 oral and maxillofacial surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin | 115 | $403 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 52 | $350 |
| Cefadroxil | 33 | $269 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 79 | $215 |
| Methylprednisolone | 27 | $182 |
| Nystatin | 12 | $164 |
| Clindamycin Hcl | 21 | $145 |
| Dexamethasone | 11 | $129 |
| Ibuprofen | 25 | $49 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 21 | $45 |
| Lorazepam | 21 | $14 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Westlake
- Mohammad RazaviCleveland$41K
- Faisal QuereshyMedina$24K
- Robert HinkleDublin$21K
- Jimmie HarperCincinnati$10K
- Brian OneillBowling Green$9K
- Timothy ConleyFairfield$9K
- Gregory PlonaNorth Olmsted$8K
- Jaclyn TomsicIndependence$8K
- William BloodNorth Olmsted$8K
- Matthew HoldshipToledo$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.